Lindenwold Advisors Prestige Consumer Healthcare Inc. Transaction History

Lindenwold Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$56.7 - $68.29 $204,800 - $246,663	-3,612 Reduced 38.78%	5,702 $326,000
Q2 2023 Aug 07, 2023	SELL	$56.28 - $63.76 $164,956 - $186,880	-2,931 Reduced 23.94%	9,314 $553,000
Q1 2023 May 05, 2023	SELL	$58.41 - $67.05 $10,163 - $11,666	-174 Reduced 1.4%	12,245 $766,000
Q4 2022 Feb 13, 2023	SELL	$49.75 - $63.89 $53,182 - $68,298	-1,069 Reduced 7.93%	12,419 $777,000
Q3 2022 Oct 28, 2022	BUY	$48.72 - $61.12 $15,298 - $19,191	314 Added 2.38%	13,488 $672,000
Q2 2022 Aug 05, 2022	SELL	$52.06 - $58.9 $6,663 - $7,539	-128 Reduced 0.96%	13,174 $775,000
Q1 2022 May 09, 2022	BUY	$52.94 - $61.88 $32,346 - $37,808	611 Added 4.81%	13,302 $704,000
Q4 2021 Feb 14, 2022	BUY	$55.41 - $63.3 $703,208 - $803,340	12,691 New	12,691 $770,000

338

50.2M

6.3K

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $3.91B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

Get notified when there are updates to the investment portfolio of Lindenwold Advisors, based on Form 13F filings with the SEC.

Stay updated on Lindenwold Advisors with notifications on news.